Hydrogels for pharmaceutical and biomedical applications

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 22, Issue 2, 2005, Pages 107-149

  Kashyap, N ^a   Kumar, N ^a   Kumar, M N V Ravi ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Bioadhesive gels; Drug delivery; Environment sensitive hydrogels; Hydrogels; Immunoisolation; Molecular imprinting; Tissue engineering; Wound dressings

Indexed keywords

ANTINEOPLASTIC AGENT; CHOLESTEROL; GLUCOSE; POLYMER;

BIOMEDICINE; BIOMIMETICS; CANCER; CELL SWELLING; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG INDUSTRY; ELECTRIC FIELD; ELECTRICITY; HYDROGEL; LIGHT; MAGNETIC FIELD; PH MEASUREMENT; PRESSURE; REVIEW; SURFACE PROPERTY; TEMPERATURE; THERMODYNAMICS; ULTRASOUND; WATER CONTENT; WOUND DRESSING; BIOMEDICAL ENGINEERING; HUMAN;

BIOMEDICAL ENGINEERING; DRUG DELIVERY SYSTEMS; HUMANS; HYDROGELS;

EID: 23244460737     PISSN: 07434863     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevTherDrugCarrierSyst.v22.i2.10     Document Type: Review

References (157)

1. Wichterle O, Lim D. Hydrophilic gels in biologic use. Nature 1960; 185:117.
2. Kishida A, Ikada Y. Hydrogels for biomedical and pharmaceutical applications. In: Dumitriu S, editor. Polymeric Biomaterials. 2 ed. New York: Marcel Dekker, 2002.
3. Kang HW, Tabata Y, Ikada Y. Fabrication of porous gelatin scaffolds for tissue engineering. Biomater 1999; 20:1339-1344.
4. Peppas NA, Huang Y, Torres-Lugo M, Ward JH, Zhang J. Physiochemical foundation and structural design of hydrogels in medicine and biology. Ann Rev Biomed Eng 2000; 2:9-29.
5. Flory PJ, Rehner BD. Statistical mechanics of crosslinked polymer networks I. Rubber like elasticity. J Chem Phys 1943; 11:512-520.
6. Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev 2002; 43: 3-12.
7. Khare AR, Peppas NA. Swelling/deswelling of anionic copolymer gels. Biomaterials 1995; 16:559-567.
8. Kim B, Flamme KL, Peppas NA. Dynamic swelling behavior of pH sensitive anionic hydrogels used for protein delivery. J Appl Polym Sci 2003; 89:1606-1613.
9. Berger J, Reist M, Mayer JM, Felt O, Peppas NA, Gurny R. Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur J Pharm Biopharm 2004; 57:19-34.
10. Mi FL, Shyu SS, Lee ST, Wong TB. Kinetic study of chitosan tripolyphosphate complexation reaction and acid resistive properties of the chitosan-tripolyphosphate gel beads prepared by in liquid curing method. J Polym Sci Part B 1999; 37:1551-1564.
11. Shu XZ, Zhu KJ, Song W. Novel pH-sensitive citrate crosslinked chitosan film for drug controlled release. Int J Pharm 2001; 212:19-28.
12. Hejazi R, Amiji M. Chitosan-based delivery systems: physiochemical properties and pharmaceutical applications. In: Dumitriu S, editor. Polymeric Biomaterials. 2 ed. New York: Marcel Dekker, 1993.
13. Peppas NA, Khare AR. Preparation, structure and diffusional behavior of hydrogels in controlled release. Adv Drug Deliv Rev 1993; 11:1-35.
14. Flory PJ, Rehner BD. Statistical mechanics of crosslinked polymer networks II: swelling. J Chem Phys 1943; 11:521-526.
15. Flory PJ. Principles of Polymer Chemistry. New York: Cornell Univ Press, 1953.
16. Huang Y, Szleifer I, Peppas NA. A molecular theory of polymer gels. Macromolecules 2002; 35:1373-1380.
17. Hennink WE, Nostrum CFv. Novel crosslinkking methods to design hydrogels. Adv Drug Deliv Rev 2002; 54:13-36.
18. Phillipp B, Dautzenberg H, Linow K-J, Kotz J, Dawydoff W. Polyelectrolye complexes-recent developments and open problems. Prog Polym Sci 1989; 14:91-172.
19. Kashyap N, Kumar N, Kumar MNVR. Smart gels for drug delivery applications. Drug Deliv Tech 2004; 4:31-35.
20. Zhong X, Wang YX, Wang SC. Pressure dependence of the volume phase transition of temperature sensitive gels. Chem Eng Sci 1996; 51:3235-3239.
21. Kwok CS, Mourad PD, Crum LA, Ratner BD. Self assembled molecular structures as ultrasonically responsive barrier membranes for pulsatile delivery. J Biomed Mater Res 2001; 57:151-164.
22. Tanaka T, Nishio I, Sun S-T, Nishio SU-R. Collapse of gels in an electric field. Science 1982; 218:467-469.
23. Sawahata K, Hara M, Yasunaga H, Osada Y. Electrically controlled drug delivery system using polyelectrolyte gels. J Control Release 1990; 14:253-262.
24. Kwon IC, Bae YH, Okano T, Kim SW. Drug release from electric current sensitive polymer. J Control Release 1991; 17:149-156.
25. Osada Y, Okuzaki H, Hori H. A polymer gel with electrically driven motility. Nature 1992; 355:242-244.
26. Edelman ER, Kost J, Bobeck H, Langer R. Regulation of drug release from polymer matrices by oscillating magnetic fields. J Biomed Mater Res 1985; 19:67-83.
27. Kost J, Wolfrum J, Langer R. Magnetically enhanced insulin release in diabetic rats. J Biomed Mater Res 1987; 21:1367-1373.
28. Mamada A, Tanaka T, Irie M. Photo-induced phase transition of gels. Macromolecules 1990; 23:1517-1519.
29. Suzuki A, Tanaka T Phase transition in polymer gels induced by visible light. Nature 1990; 346:345-347.
30. Okuyama Y, Yoshida R, Sakai K, Okano T, Sakurai Y. Swelling controlled zero order and sigmoidal drug release from thermoresponsive poly(N- isopropylacrylamide-co-butyl methacrylate) hydrogels. J Biomater Sci polym 1993; 4:545-556.
31. Katono H, Maruyama A, Sanui K, Okano T, Sakurai Y. Thermoresponsive swelling and drug release switching of interpenetrating polymer networks composed of poly(acrylamide-co-butyl methacrylate) and poly(acrylamide).J Control Release 1991; 16:215-227.
32. Ghandehari H, Kopeckova P, Kopecek J. In vitro degradation of pH sensitive hydrogels containing azo bonds. Biomaterials 1997; 18:861-872.
33. Siegel RA, Falamarzian M, Firestone BA, Moxley BC. pH controlled release from hydrophobic/polyelectrolyte copolymer hydrogels. J Control Release 1988; 8:179-182.
34. Patel VR, Amiji MM. Preparation and characterization of freeze dried chitosan-poly(ethylene oxide) hydrogels for site specific antibody delivery in the stomach. Pharm Res 1996; 13:588-593.
35. Kim JJ, Park K. Modulated insulin delivery from glucose sensitive hydrogel dosage forms. J Control Release 2001; 77:39-47.
36. Kitano S, Koyama Y, Kataoka K, Okano T, Sakurai Y. A novel drug delivery system utilizing a glucose responsive polymer complex between poly(vinyl alcohol) and poly(N-vinyl-2-pyrrolidone) with a phenylboronic acid moiety. J Control Release 1992; 19: 162-170.
37. Shiino D, Murata Y, Kubo A, Kim YJ, Kataoka K, Koyama Y, Kikuchi A, Yokoyama M, Okano T. Amine containing phenylboronic acid gel for glucose-responsive insulin release under physiological pH. J Control Release 1995; 37:269-276.
38. Chung DJ, Ito Y, Imanishi Y. An insulin-releasing membrane systems on the basis of oxidation reaction of glucose. J Control Release 1992; 18:45-54.
39. Podual K, Doyle FJI, Peppas NA. Glucose-sensitivity of glucose oxidase-containing cationic copolymer hydrogels having poly(ethylene glycol) grafts. J Control Release 2000; 67:9-17.
40. Podual K, Doyle FJI, Peppas NA. Preparation and dynamic response of cationic copolymer hydrogel containing glucose oxidase. Polymer 2000; 41:3975-3983.
41. Derjaguin BV, Smilga VP. Adhesion: Fundamentals and Practice. London: McLaren, 1969.
42. McBain JW, Hopkins DG. On adhesives and adhesives actions. J Phys Chem 1925; 29:188-204.
43. Kinloch AJ. The science of adhesion: I. Surface and interfacial aspects. J Mater Sci 1980; 15:2141-2141.
44. Reinhart CP, Peppas NA. Solute diffusion in swollen membranes II. Influence of crosslinking on diffusion properties. J Membrane Sci 1984; 18:227-239.
45. Huntsberger JR. Mechanism of adhesion. J Paint Techn 1967; 39:199-211.
46. Woolfson AD, Malcolm RK, McCarron PA, Jones DS. Bioadhesive drug delivery systems. In: Dumitriu S, editor. Polymeric Biomaterials. 2 ed. New York: Marcel Dekker, 2002.
47. Robinson JR, Mlynek GM. Bioadhesive and phase-change polymers for ocular drug delivery. Adv Drug Deliv Rev 1995; 16:45-50.
48. Needleman IG, Martin GP, Smales FC. Characterization of bioadhesives for peridontal and oral mucosal drug delivery. J Clin Periodontal 1998; 25:74-82.
49. Tamburic S, Graig DQM. Rheological evaluation of polyacrylic acid hydrogels. Pharm Sci 1995; 1:107-109.
50. Eouani C, Piccerelle P, Prinderre P, Bourret E, Joachim J. In-vitro comparative study of buccal mucoadhesive performance of different polymeric films. Eur J Pharm Biopharm 2001; 52:45-55.
51. Weidner J. Monitor: drug delivery. Drug Discov Today 2003; 8:906-907.
52. Hui HW, Robinson JR. Ocular drug delivery of progesterone using a bioadhesive polymer. Int J Pharm 1985; 1:203-213.
53. Bernkop-Schnurch A, Krauland AH, Leitner VM, Palmberger T. Thiomers: potential excipients for non-invasive peptide delivery systems. Eur J Pharm Biopharm 2004; In Press.
54. Hornof M, Weyenberg W, Ludwig A, Bernkop-Schnurch A. Mucoadhesives ocular inserts based on thiolated poly(acrylic acid): development and in vivo evaluation in humans. J Control Release 2003; 89:419-428.
55. Richardson JL, Illum L. The vaginal route of peptide and protein drug delivery. Adv Drug Deliv Rev 1992; 8:341-366.
56. Valenta C, Kast CE, Harich I, Bernkop-Schnurch A. Development and in vitro evaluation of a mucoadhesive vaginal delivery system for progesterone. J Control Release 2001; 77:323-332.
57. Nagai T, Machida Y. Advances in drug delivery-mucosal adhesive dosage forms. Pharm Int 1985; 6:196-200.
58. Woolfson AD, McCaffertty DF, McCarron PA, Price JH. A bioadhesive patch cervical drug delivery system for administration of 5-flurouracil to cervical tissue. J Control Release 1995; 35:49-58.
59. Junginger HE. Bioadhesive polymer system for peptide delivery. Acta Pharm Technol 1990; 36:110-160.
60. Lehr C-M. Bioadhesion technologies for the drug delivery of peptide and protein drugs to gastrointestinal tract. Crit Rev Ther Drug Carrier Syst 1994; 11:119-160.
61. Bernkop-Schnurch A, Krajicek ME. Mucoadhesive polymer as platform for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugate. J Control Release 1998; 50:215-223.
62. Kim B, Peppas NA. Analysis of molecular interaction in poly(methacrylic acid-g-ethylene glycol) hydrogel. Polymer 2003; 44:3701-3707.
63. Nakamura K, Murray RJ, Joseph JI, Peppas NA, Morishita M, Lowman AM. Oral insulin delivery using P(MAA-g-EG) hydrogels: effect of network morphology on insulin delivery characteristics. J Control Release 2004; 95:589-599.
64. Morishita M, Goto T, Peppas NA, Joseph JI, Torjman MC, Munsicks C, Nakamura K, Yamagata T, Takayama K, Lowman AM. Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption. J Control Release 2004; 97:115-124.
65. Haas J, Lehr C-M. Developments in the area of bioadhesive drug delivery systems. Expert Opin Ther 2002; 2:287-298.
66. Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chem Rev 2001; 101:1869-1879.
67. Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 2003; 24:4337-4351.
68. Kast CE, Frick W, Losert U, Bernkop-Schnurch A. Chitosan-TGA conjugates: a new scaffold material for tissue engineering. Int J Pharm 2003; 256:183-189.
69. Kumar MNVR, Muzzarelli RAA, Muzzarelli C, Sashiwa H, Domb AJ. Chitosan chemistry and pharmaceutical perspectives. Chem Rev 2004; 104:6017-6084.
70. Mao JS, Zhao L, Yin YJ, Yao KD. Structure and properties of bilayer chitosan-gelatin scaffolds. Biomaterials 2003; 24:1067-1074.
71. Mao JS, Zhao L, Yao KD, Shang Q, Yang G, Cao Y. Study of novel chitosan-gelatin artificial skin in vitro. J Biomed Mater Res Part A 2003; 64A:301-308.
72. Kuo CK, Ma PX. Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: Part 1. Structure, gelation rate and mechanical properties. Biomaterials 2001; 22:511-521.
73. Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 1999; 20:45-53.
74. Lai HL, Khalil AA, Craig DQM. The preparation and characterization of drug loaded alginate and chitosan sponges. Int J Pharm 2003; 251:175-181.
75. Yang J, Chung TW, Nagaoka M, Goto M, Cho C-S, Akaike T. Hepatocyte-specific porous polymer scaffold of alginate/galactosylated chitosan sponge for liver tissue engineering. Biotechnol Lett 2001; 23:1385-1389.
76. Southern LJ, Hughes H, Lawford PV, Clench MR, Manning NJ. Glutaraldehyde induced crosslinks: a study of model compounds and commercial bioprosthetic valves. J Heart Valve Dis 2000; 9:241-248.
77. Kaufmann PM, Heimrath S, Kim BS, Mooney DJ. Highly porous polymer matrices as a three dimensional culture system for hepatocytes. Cell Transplant 1997; 6:463-468.
78. Seliktar D, Black RA, Vito RP, Nerem RM. Dynamic mechanical conditioning of collagen gel blood vessel constructs induces remodelling in vitro. Ann Biomed Eng 2000; 28:351-362.
79. Mattew HWT. Polymers for tissue engineering scaffolds. In: Dumitriu S, editor. Polymeric Biomaterials. 2 ed. New York: Marcel Dekker, 2002.
80. Zhu H, Ji J, Lin R, Gao C, Shen J. Surface engineering of poly(D,L-lactic acid) by entrapment of chitosan-based derivatives for the promotion of chondrogenesis. J Biomed Mater Res 2002; 64:532-539.
81. Panitch A, Yamaoka T, Fournier MJ, Masson TL, Tirrell DA. Elastin-like extracellular-matrix proteins containing periodically spaced fibronectin CS5 domains gives to design and biosynthesis. Macromolecules 1999; 32:1701-1703.
82. Holmes TC. Novel peptides-based biomaterial scaffolds for tissue engineering.Trends Biotech 2002; 20:16-21.
83. Nguyen KT, West JL. Photopolymerizable hydrogels for tissue engineering applications. Biomaterials 2002; 23:4307-4314.
84. Elisseeff J, McIntosh W, Anseth K, Riley S, Ragan P, Langer R. Photoencapsulation of chondrocytes in poly(ethylene oxide) based semi interpenetrating networks. J Biomed Mater Res 2000; 51:164-171.
85. Byrne ME, Park K, Peppas NA. Molecular imprinting within hydrogels. Adv Drug Deliv Rev 2002; 54:149-161.
86. Lorenzo CA, Concheiro A. Molecularly imprinted polymers for drug delivery. J Chromtogr B 2004; 804:231-245.
87. Haginaka J, Takehira H, Hosoya K, Tanaka N. Uniform-sized molecularly imprinted polymer for (S)-naproxen selectively modified with hydrophilic external layer. J Chromtogr A 1999; 849:331-339.
88. Bures P, Huang Y, Oral E, Peppas NA. Surface modifications and molecular imprinting of polymers in medical and pharmaceutical applications. J Control Release 2001; 72:25-33.
89. Hilt JZ, Byrne ME. Configurational biomimesis in drug delivery: molecular imprinting of biologically significant molecules. Adv Drug Deliv Rev 2004; 56:1599-1620.
90. Lu ZR, Kopeckova P, Kopecek J. Polymerizable fab antibody fragments for targeting of anticancer drugs. Nat Biotechnol 1999; 17:1101-1104.
91. Kokufuta E, Zhang YQ, Tanaka T. Saccharide-sensitive phase transition of lectin-loaded gel. Nature 1991; 351:302-304.
92. Obaidat AA, Park K. Characterization of glucose dependent gel-sol phase transition of polymeric glucose-concanvalin A hydrogel system. Pharm Res 1996; 13:989-995.
93. Baba Y, Tsuhako M, Saqa T, Akashi M, Yashima E. Specific base recognition of oligodeoxynucleotides by capillary affinity gel electrophoresis using polyacrylamide poly(9-vinyladenine) conjugated gel. Anal Chem 1992; 64:1920-1925.
94. Bulmus V, Ding Z, Long CJ, Stayton PS, Hoffman AS. Site-specific polymer-streptavidin bioconjugate for pH-controlled binding and triggered release of biotin. Bioconjug Chem 2000; 11:78-83.
95. Allender CJ, Richardson C, Woodhouse B, Heard CM, Brain KR. Pharmaceutical applications for molecularly imprinted polymer. Int J Pharm 2000; 195:39-43.
96. Sudee R, Srichana T, Rattananont T. Enantioselective release of controlled delivery granules based on molecularly imprinted polymer. Drug Deliv 2002; 9:19-30.
97. Guo K, Huang L, Oral E, Peppas NA. Solid core liposomes with encapsulated gold particles. Biochim Biophys Acta 1987; 897:377-383.
98. Zong N, Byun HS, Bittman R. Hydrophilic cholesterol binding molecular imprinted polymer. Tetrahedron Lett 2001; 42:1839-1841.
99. Langer R, Peppas NA. Advances in biomaterials, drug delivery, and nanotechnology. AIChE J 2003; 49:2990-3006.
100. Helfman T, Ovington L, Falanga V. Occlusive dressings and wound healing. Clin Dermatol 1994; 12:121-127.
101. Cho YW, Cho YN, Chung SH, Yoo G, Ko SW. Water soluble chitin as wound healing accelarator. Biomaterials 1999; 20:
102. Neill MAAO, Vine GJ, Beezer AE, Bishop AH, Hadgraft J, Labetoulle C, Walker M, Bowler PG. Antimicrobial properties of silver containing wound dressings: a microcalometric study. Int J Pharm 2003; 263:61-68.
103. Brown AS. Hydron for burns. Plast Reconstruct Surg 1981; 67:810-811.
104. Yates DW, Hadfield JM. Clinical experiance with a new hydrogel wound dressing. Injury 1984; 16:23-24.
105. Myers JA. Delperm: a nontextile wound dressing. Pharm J 1983; 230:263.
106. Lugao AB, Malmonge SM. Use of radiation in the production of hydrogels. Nucl Instrum Method Phys Res Section B: Beam Interact Mater Atoms 2001; 185:37-42.
107. Lugao AB, Rogero SO, Malmonge SM. Rheological behavior of irradiated wound dressing poly(vinyl pyrrolidone) hydrogels. Rad Phys Chem 2002; 63:543-546.
108. Yusof NLM, Lim LY, Khor E. Preparation and characterization of chitin beads as wound dressing precursors. J Biomed Mater Res 2001; 54:59-68.
109. Ishihara M, Nakanishi K, Ono K, Sato M, Kikuchi M, Saito Y, Yura H, Matsui T, Hattori H, Uenoyama M, Kurita A. Photocrosslinkable chitosan as dressing for wound occlusion and accelarator in healing process. Biomaterials 2002; 23:833-840.
110. Khor E, Lim LY. Implantable applications of chitin and chitosan. Biomaterials 2003; 23:2339-2349.
111. Kirker KR, Luo Y, Morris SE, Shelby J, Prestwich GD. Glycosaminoglycan hydrogel as supplemental wound dressings for donor sites. J Burns Care Rehab 2004; 25: 276-286.
112. Kirker KR, Luo Y, Nielson JH, Shelby J, Prestwich GD. Glycosaminoglycan hydrogel films as bio-interactive dressings for wound healing. Biomaterials 2002; 23:3661-3671.
113. Singla AK, Chawla M. Chitosan: some pharmaceutical and biological aspects-an update. J Pharm Pharmcol 2001; 53:1047-1067.
114. Shapiro L, Cohen S. Novel alginate sponges for cell culture and transplantation. Biomaterials 1997; 18:583-590.
115. Hashimoto T, Suzuki Y, Tanihara M, Kakimaru Y, Suzuki K. Develpoment of alginate wound dressings linked with hybrid peptides derived from laminin and elastin. Biomaterials 2004; 25:1407-1414.
116. Kim HJ, Choi EY, Oh JS, Lee HC, Park SS, Cho CS. Possibility of wound dressing using poly(L-leucine)/poly(ethylene glycol)/poly(L-leucine) triblock copolymer. Biomaterials 2000; 21:131-141.
117. Lanza RP, W.L.Chick. Immunoisolation: at a turning point. Immunol Today 1997; 18:135-139.
118. Rihova B. Immunocompatibility and biocompatibility of cell delivery systems. Adv Drug Deliv Rev 2000; 42:65-80.
119. Chang TMS. Semipermeable microcapsules. Science 1964; 146:524-525.
120. Uludag H, Hwang JR, Sefton MV. Microencapsulated human hepatoma(HepG2) cells. Capsule to capsule variation in protein secretion and permeability. J Control Release 1995; 33:273-283.
121. Wang TG. New technologies for bioartificial organs. Artific Organs 1998; 22: 68-74.
122. Iwata H, Kobayashi K, Takagi T, Oka T, H. Yang, Amemiya H, T. Tsuji, Ito F. Feasibilty of agarose microbeads with xenogenic islet as a bioartificial pancreas. J Biomed Mater Res 1994; 28:1003-1011.
123. Vos PD, Wolters GH, Fritschy WM, Schilfgaarde Rv. Obstacles in the application of microencapsulation in islet transplantation. Int J Artif Organs 1993; 16:205-212.
124. Brauker J, Martinson LA, Young SK, Johnson RC. Local inflammatory response around diffusion chamber containing xenografts. Nonspecific destruction of tissue and decreased local vascularization. Transplantation 1996; 61:1671-1677.
125. Chick WL, Like AA, Lauris Y, Galletti PM, Richardson PD, Panol G, Mix TW, Colton CK. A hybrid artificial pancreas. Trans Am Soc Intern Organs 1975; 21:8-14.
126. Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980; 210:908-910.
127. Reach G, Poussier P, Sausse A, Assan R, Itoh M, Gerich JE. Functional evaluation of a bioartificial pancreas using isolated islets perfused with blood ultrafilterate. Diabetes 1981; 30:296-301.
128. Calafiore R. Bioartificial pancreas. In: Dumitriu S, editor. Polymeric Biomaterials. 2 ed. New York: Marcel Dekker, 2002.
129. Lee MK, Bae YH. Cell transplantation for endocrine disorders. Adv Drug Deliv Rev 2000; 42:103-120.
130. Lanza RP, Beyer AM, Staruk JE, W.L.Chick. Bioartificial pancreas: long term function of discordant islets, xenografts in streptozotocin diabetic rats. Transplantation 1993; 56:1067-1072.
131. Lanza RP, Sullivan SJ, W.L.Chick. Treatment of severly diabetic, pancreatectomized dogs using a diffusion based hybrid pancreas. Diabetes 1992; 41:886-889.
132. Ward RS, White KA, Wolcott CA, Wang AY, Kuhn RW, Taylor JE, John JK. Development of hybrid artificial pancreas with a dense polyurethane membrane. ASAIO J 1993; 39:M261-M267.
133. Chen GX, Peng Y, Lou PL, Liu JP. Bioartificial thyroid. The in vitro culture of microencapsulated rabbit thyroid tissue. ASAIO J 1991; 37:M439-M440.
134. Braun K, Kauert C, Weber A, Dorsche HHv, Hahn HJ. Syngeneic transplantation of thyroid tissue encapsulated in cellulose sulfate membrane. Z Exp Chir Transplant Kunstliche Organe 1988; 21:58-64.
135. Wozneiwicz B, Migaj M, Guera B, Prokurat A, Tolloczko T, Sawicki A, Nawrot I, Gorski A, Zabitkowska T, Kossakowska AE. Cell culture preparation of human parathyroid cells for allotransplantation without immunosuppression. Transplant Proc 1996; 28:3542-3544.
136. Hasse C, Klock G, Schlosser A, Zimmermann U, Rothmund M. Parathyroid tissue without immunosupression. Transplantation 1983; 36:599-602.
137. Abobaker AM. Free and microencapsulated adrenal cortical cells produce similar cortisol response when stimulated by ACTH: an in vitro study. Int J Artif Organs 1994; 17:171-174.
138. Orive G, Hernandez RM, Gascon RA, Igartua M, Pedraz JL. Encapsulated cell technology: from research to market. Trends Biotech 2002; 20:382-387.
139. Zeman SP-O. Regenerative medicine. Nat Biotechnol 2001; 19:201-206.
140. Packnaeuser CB, Schnieders J, Oster CG, Kissel T. In situ forming parenteral drug delivery systems: an overview. Eur J Pharm Biopharm 2004; In press.
141. Bos GW, Verrijk R, Hennink WE, Crommelin DJA. Controlled release of pharmaceutical proteins from hydrogels. Business Brief Pharma Tech 2002; 184-187.
142. Chenite A, Chaput C, Wang D, Combes C, Buschmann MD, Hoemann CD, Leroux JC, Atkinson BL, Binette F, Selmani A. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 2000; 21:2155-2161.
143. Gariepy ER-O, Chenite A, Chaput C, Guirguis S, Leroux J-C. Characterization of thermosensitive chitosan gels for the sustained delivery of drugs. Int J Pharm 2000; 203:89-98.
144. Chenite A, Buschmann M, Wang D, Chaput C, Kandani N. Rheological characterisation of thermogelling chitosan/glycerol-phosphate solutions. Carbohydr Polym 2001; 46:39-47.
145. Jong SJ, Eerdenbrugh Bv, Nostrum CFv, Bosch JJK-vd, Hennink WE. Physically crosslinked dextran hydrogels by stereocomplex formation of lactic acid oligomers: degradation and protein release behavior. J Control Release 2001; 71:261-275.
146. Jong SJ, Smedt SCd, Demeester J, Nostrum CFv, Bosch JJK-vd, Hennink WE. Biodegradable hydrogels based on stereocomplex formation between lactic acid oligomers grafted to dextran. J Control Release 2001; 72:47-56.
147. Hennink WE, Jong SJ, Bos GW, Veldhuis TFJ, Nostrum CFv. Biodegradble dextran hydrogel crosslinked by stereocomplex formation for the controlled release of pharmaceutical proteins. Int J Pharm 2004; 277:99-104.
148. Peppas NA, Keys KB, Lugo MT, Lowman AM. Poly(ethylene glycol)-containing hydrogels in drug delivery. J Control Release 1999; 62:81-87.
149. Vinogradov SV, Bronich TK, Kabanov AV. Nanosized cationic hydrogels for drug delivery: prepartion, properties and interaction with cells. Adv Drug Deliv Rev 2002; 54:135-147.
150. Huang G, Gao J, Hu Z, John JV, Ponder BC, Moro D. Controlled drug release from hydrogel nanoparticles network. J Control Release 2004; 94:303-311.
151. Sahoo SK, De TK, Ghosh PK, Maitra A. pH- and thermo-sensitive hydrogel nanoparticles. J Colloid Interf Sci 1998; 206:361-368.
152. Teder H, Johnsson CJ. The effect of different dosage of degradable starch microsphere(spherex) on the distribution of doxorubicin regionally administered to the rat. Anticancer Res 1993; 13:2161-2164.
153. Deurloo MJ, Kop W, Tellingen Ov, Bartelink H, Begg AC. Intratumoural administration of cisplatin in slow release devices: II pharmacokinetic and intratumoural distribution. Cancer Chemother Pharmacol 1991; 27:347-353.
154. Jeyanthi R, Rao KP. Controlled release of anticancer drugs from collagen-poly(hydroxyethyl methacrylate) hydrogel matrices. J Control Release 1990; 13:91-98.
155. Jeyanthi R, Rao KP. In vivo biocompatibility of collagen- poly(hydroxyethyl methacrylate) hydrogels. Biomaterials 1990; 11:238-243.
156. Cerchiara T, Luppi B, Bigucci F, Orienti I, Zecchi V. Physically crosslinked chitosan hydrogels as topical vehical for hydrophilic drugs. J Pharm Pharmacol 2002; 54: 1453-1459.
157. Lee C-H, Chien YW. Development and evaluation of a mucoadhesive drug delivery system for dual-controlled delivery of nonoxynol-9. J Control Release 1996; 39: 93-103.